Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
AG, aim, AskBio, Bayer, bore, Brexit, Centre, cessation, Consortium, constitutionality, contemplated, customary, designee, divested, divestiture, Excellence, extinguishment, field, frame, GeneCradle, goodwill, incurrence, introduced, licensee, maximize, maximizing, NICE, passage, passed, payoff, Pharma, recommend, repaid, Republic, resolution, roadmap, Scottish, SMC, speculation, TDP, thereof, therewith, timetable, toolkit, Toxicology, winding, wrongdoing
Removed:
account, antibody, assume, bear, calculate, calculation, Chiesi, CIRM, collateral, creditor, cytogenetic, declare, deficiency, Diego, Directive, dispose, drawdown, embodied, embodying, flexibility, function, grantee, Graphite, Horizon, importer, irrevocable, Jasper, Leadiant, mature, measure, monoclonal, Mylan, optimization, originally, owe, owner, partly, preference, prospect, publicly, Recordati, refinance, register, renal, replace, resurgence, San, screening, tailor, title, UCSD, unpaid
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view